FDA to put most serious warning on COVID-19 vaccines
Digest more
Pfizer said on Tuesday it entered into an exclusive licensing agreement with YaoPharma, a subsidiary of China's Shanghai ...
Pfizer Is Still Struggling to Replace Its COVID Revenue. Here's What We Could See From the Pharmaceutical Giant in 2026. Keep ...
MedPage Today on MSN
RFK Jr.’s Former Group Urges FDA to Revoke COVID Vax Licenses
An anti-vaccine organization founded by HHS Secretary Robert F. Kennedy Jr. is urging the FDA he now oversees to pull the ...
Pfizer’s Tukysa added to maintenance therapy significantly delayed disease progression in patients with HER2-positive ...
Pfizer is paying top dollar for a GLP-1 candidate from Fosun Pharma. Zealand Pharma penned a platform deal with brand new ...
Pfizer (PFE) is reiterated as a Buy, supported by the world's largest drug pipeline and trading below intrinsic value, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback